PK Pharmacare Ltd - Accounts to registrar (filleted) - small 23.2.5

PK Pharmacare Ltd - Accounts to registrar (filleted) - small 23.2.5


IRIS Accounts Production v24.1.4.33 06697052 Board of Directors Board of Directors 1.10.22 30.9.23 30.9.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh066970522022-09-30066970522023-09-30066970522022-10-012023-09-30066970522021-09-30066970522021-10-012022-09-30066970522022-09-3006697052ns15:EnglandWales2022-10-012023-09-3006697052ns14:PoundSterling2022-10-012023-09-3006697052ns10:Director12022-10-012023-09-3006697052ns10:Director22022-10-012023-09-3006697052ns10:PrivateLimitedCompanyLtd2022-10-012023-09-3006697052ns10:SmallEntities2022-10-012023-09-3006697052ns10:AuditExempt-NoAccountantsReport2022-10-012023-09-3006697052ns10:SmallCompaniesRegimeForDirectorsReport2022-10-012023-09-3006697052ns10:SmallCompaniesRegimeForAccounts2022-10-012023-09-3006697052ns10:FullAccounts2022-10-012023-09-300669705212022-10-012023-09-3006697052ns10:RegisteredOffice2022-10-012023-09-3006697052ns5:CurrentFinancialInstruments2023-09-3006697052ns5:CurrentFinancialInstruments2022-09-3006697052ns5:ShareCapital2023-09-3006697052ns5:ShareCapital2022-09-3006697052ns5:RetainedEarningsAccumulatedLosses2023-09-3006697052ns5:RetainedEarningsAccumulatedLosses2022-09-3006697052ns5:NetGoodwill2022-10-012023-09-3006697052ns5:IntangibleAssetsOtherThanGoodwill2022-10-012023-09-3006697052ns5:NetGoodwill2022-09-3006697052ns5:NetGoodwill2023-09-3006697052ns5:NetGoodwill2022-09-3006697052ns5:PlantMachinery2022-09-3006697052ns5:PlantMachinery2022-10-012023-09-3006697052ns5:PlantMachinery2023-09-3006697052ns5:PlantMachinery2022-09-3006697052ns5:AdditionsToInvestments2023-09-3006697052ns5:CostValuation2023-09-3006697052ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-09-3006697052ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-09-30
REGISTERED NUMBER: 06697052 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023

FOR

PK PHARMACARE LTD

PK PHARMACARE LTD (REGISTERED NUMBER: 06697052)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


PK PHARMACARE LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2023







DIRECTORS: Mrs P Shah
K Shah





REGISTERED OFFICE: 364-368 Cranbrook Road
Gants Hill
Ilford
Essex
IG2 6HY





REGISTERED NUMBER: 06697052 (England and Wales)





ACCOUNTANTS: Prestons
Chartered Accountants
364-368 Cranbrook Road
Gants Hill
Ilford
Essex
IG2 6HY

PK PHARMACARE LTD (REGISTERED NUMBER: 06697052)

BALANCE SHEET
30 SEPTEMBER 2023

30.9.23 30.9.22
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 116,592 139,916
Tangible assets 5 3,683 2,481
Investments 6 172,000 -
292,275 142,397

CURRENT ASSETS
Stocks 96,076 35,750
Debtors 7 327,514 257,974
Cash at bank and in hand 580,658 636,357
1,004,248 930,081
CREDITORS
Amounts falling due within one year 8 210,311 222,029
NET CURRENT ASSETS 793,937 708,052
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,086,212

850,449

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 1,086,112 850,349
1,086,212 850,449

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

PK PHARMACARE LTD (REGISTERED NUMBER: 06697052)

BALANCE SHEET - continued
30 SEPTEMBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 June 2024 and were signed on its behalf by:




K Shah - Director



Mrs P Shah - Director


PK PHARMACARE LTD (REGISTERED NUMBER: 06697052)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023

1. STATUTORY INFORMATION

PK Pharmacare Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net income receivable from sale of goods and services in the year, excluding value added tax.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


PK PHARMACARE LTD (REGISTERED NUMBER: 06697052)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2023

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2022 - 6 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 October 2022
and 30 September 2023 604,485
AMORTISATION
At 1 October 2022 464,569
Charge for year 23,324
At 30 September 2023 487,893
NET BOOK VALUE
At 30 September 2023 116,592
At 30 September 2022 139,916

PK PHARMACARE LTD (REGISTERED NUMBER: 06697052)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2023

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 October 2022 11,765
Additions 1,604
At 30 September 2023 13,369
DEPRECIATION
At 1 October 2022 9,284
Charge for year 402
At 30 September 2023 9,686
NET BOOK VALUE
At 30 September 2023 3,683
At 30 September 2022 2,481

6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
Additions 172,000
At 30 September 2023 172,000
NET BOOK VALUE
At 30 September 2023 172,000

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.23 30.9.22
£    £   
Trade debtors 83,974 92,753
Other debtors 243,540 165,221
327,514 257,974

PK PHARMACARE LTD (REGISTERED NUMBER: 06697052)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2023

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.23 30.9.22
£    £   
Trade creditors 118,812 117,942
Taxation and social security 68,653 49,921
Other creditors 22,846 54,166
210,311 222,029